Apimeds Pharmaceuticals US APUS Q3 2025 earnings

FAQ

When did Apimeds Pharmaceuticals US report Q3 2025 earnings?

Apimeds Pharmaceuticals US (APUS) reported Q3 2025 earnings on November 12, 2025 before market open.

What were Apimeds Pharmaceuticals US's Q3 2025 revenue and EPS?

Apimeds Pharmaceuticals US reported eps of $-0.14 for Q3 2025.

How did Apimeds Pharmaceuticals US's Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, eps declined 434.4% from $-0.03.

Where can I find Apimeds Pharmaceuticals US's Q3 2025 SEC filings?

You can read the 10-Q periodic report (0001213900-25-109280) directly on SEC EDGAR. The filing index links above go to sec.gov.